[Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
Derhy
S
S
Bessis
L
L
Atallah
R
R
Ajavon
Y
Y
Eisele
G
G
Roche
A
A
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007269:Injections, Intra-Arterial; D007459:Iodized Oil / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011169:Portal Vein; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000209:etiology
D007459:Iodized Oil; D004317:Doxorubicin
Reperméabilisation portale après chimiothérapie lipiodolée intra-artérielle au cours d'un carcinome hépatocellulaire. A propos de 3 cas.